Berdugo, M., Delaunay, K., Lebon, C., Naud, M., Radet, L., Zennaro, L., . . . Behar-Cohen, F. F. (2021). Long-Term Oral Treatment with Non-Hypoglycemic Dose of Glibenclamide Reduces Diabetic Retinopathy Damage in the Goto-KakizakiRat Model. Pharmaceutics.
Citación estilo ChicagoBerdugo, Marianne, et al. "Long-Term Oral Treatment With Non-Hypoglycemic Dose of Glibenclamide Reduces Diabetic Retinopathy Damage in the Goto-KakizakiRat Model." Pharmaceutics 2021.
Cita MLABerdugo, Marianne, et al. "Long-Term Oral Treatment With Non-Hypoglycemic Dose of Glibenclamide Reduces Diabetic Retinopathy Damage in the Goto-KakizakiRat Model." Pharmaceutics 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.